Wealthcare Capital Management LLC Abb Vie Inc. Transaction History

Wealthcare Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $43,767 - $48,759	-416 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $42,556 - $46,849	416 New	416 $45,000
Q2 2020 Jul 29, 2020	SELL	$73.37 - $98.18 $2,861 - $3,829	-39 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $4,192 - $6,356	-65 Reduced 62.5%	39 $3,000
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $7,501 - $9,386	104 New	104 $9,000
Q2 2017 Aug 22, 2017	SELL	N/A	-80 Closed	0 $0
Q1 2016 Sep 20, 2017	BUY	N/A	80	80 $5,000

3,846

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Wealthcare Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Capital Management LLC with notifications on news.